Phyton shares new article published by iScience that demonstrates that QS-21 produced via plant cell culture for saponin-derived vaccine adjuvants can be commercially produced in a sustainable way
Phyton Biotech is pleased to announce a recent publication by iScience showcasing the successful application of its plant cell fermentation platform to derive an important compound.